OTCMKTS:OPSSF Opsens (OPSSF) Stock Price, News & Analysis → Will this AI Micro-Cap be Bigger than NVIDIA? (From Behind the Markets) (Ad) Free OPSSF Stock Alerts $2.14 +0.01 (+0.64%) (As of 12/13/2023) Add Compare Share Share Today's Range$2.12▼$2.1450-Day Range$2.14▼$2.1452-Week Range$0.97▼$2.14Volume36,000 shsAverage Volume44,497 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisAnalyst ForecastsStock AnalysisAnalyst Forecasts Get Opsens alerts: Email Address Ad Behind the MarketsThe Military's $700M "AI Software Bullet"The Pentagon is spending over $700 MILLION on a top-secret project called "Overmatch." It's a software-defined networking solution that will connect all sensors, weapons, platforms, and personnel across our military branches.Get the name and stock ticker of this critical military tech firm HERE>>> About Opsens Stock (OTCMKTS:OPSSF)Opsens Inc. develops, manufactures, installs, and sells fiber optic sensors for cardiovascular interventions. The company operates in two segments, Medical and Industrial. The company provides advanced optical-based pressure guidewire (OptoWire), a guidewire used in the transcatheter aortic valve replacement procedure; and a range of miniature optical sensors to measure pressure and temperature to be used in a range of applications that can be integrated in other medical devices. It also develops, manufactures, and markets medical products; and offers OPP-GD fiber optic differential pressure sensors and the OEC fiber optic extensometer sensors. The company serves life sciences, energy, defense and aerospace, geotechnical, civil engineering, scientific laboratory, and various other markets. The company sells its products through a network of distributors and direct sales force in the United States, Japan, Canada, and internationally. Opsens Inc. was formerly known as Capital DCB inc. and changed its name to OpSens Inc. in October 2006. The company was founded in 2003 and is headquartered in Québec, Canada.Read More OPSSF Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart OPSSF Stock News HeadlinesNovember 22, 2023 | marketwatch.comOpsens 4Q Loss Narrows, Revenue Tops ViewsNovember 2, 2023 | finance.yahoo.comOPSENS RECEIVES INTERIM ORDER AND FILES MANAGEMENT INFORMATION CIRCULAR IN CONNECTION WITH SPECIAL MEETING OF SHAREHOLDERSOctober 23, 2023 | finance.yahoo.comOPSENS ANNOUNCES THE POSITIVE CLINICAL RESULTS FROM THE SAFE-TAVI STUDY WITH SAVVYWIRE IN EUROPEOctober 17, 2023 | finance.yahoo.comOpSens to Participate in the Transcatheter Cardiovascular Therapeutics Conference (TCT) in San Francisco October 23 - 26, 2023October 5, 2023 | finance.yahoo.comOpsens' (TSE:OPS) investors will be pleased with their impressive 150% return over the last three yearsJune 20, 2023 | finance.yahoo.comOPS.TO - Opsens Inc.April 20, 2023 | finance.yahoo.comOpSens Announces Participation in the 2023 Bloom Burton & Co. Healthcare Investor ConferenceApril 6, 2023 | finance.yahoo.comOPSENS TO HOST SECOND QUARTER FISCAL YEAR 2023 FINANCIAL RESULTS CONFERENCE CALL ON THURSDAY APRIL 13, 2023February 28, 2023 | finance.yahoo.comOPSENS ANNOUNCES SAVVYWIRE™ USED DURING TWO LIVE CASES AT CRT CONFERENCEJanuary 12, 2023 | finance.yahoo.comOPSENS ANNOUNCES RECORD FIRST QUARTER FISCAL 2023 FINANCIAL RESULTSJanuary 11, 2023 | markets.businessinsider.comOpsens earnings: here's what Wall Street expectsJanuary 5, 2023 | finance.yahoo.comOPSENS TO HOST FIRST QUARTER FISCAL YEAR 2023 FINANCIAL RESULTS CONFERENCE CALL ON THURSDAY JANUARY 12, 2023December 22, 2022 | finance.yahoo.comOPSENS ANNOUNCES CLOSING OF $11.5 MILLION BOUGHT DEAL PUBLIC OFFERING INCLUDING $1.5 MILLION OVER-ALLOTMENT OPTION EXERCISED IN FULLNovember 29, 2022 | finance.yahoo.comOPSENS ANNOUNCES FIRST SAVVYWIRE™ PROCEDURE IN NEW ZEALANDSeptember 15, 2022 | finance.yahoo.comPromaxo Announces Research Collaboration with the University of Montreal Hospital Research Centre (CRCHUM) for Improved Prostate, Female GYN Cancer Management - Yahoo FinanceSeptember 15, 2022 | finance.yahoo.comInhibikase Therapeutics to Present Data from Phase 1/1b study of IkT-148009 at the Movement Disorders Society Congress - Yahoo FinanceSeptember 15, 2022 | finance.yahoo.comOPSENS ANNOUNCES FDA CLEARANCE FOR THE SAVVYWIRE™ FOR USE IN TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) PROCEDURESSeptember 14, 2022 | finance.yahoo.comOpSens to Participate in the Transcatheter Cardiovascular Therapeutics Conference (TCT) in Boston September 16-19, 2022 - Yahoo FinanceAugust 21, 2022 | finance.yahoo.comOpsens Inc. (OPSSF)July 15, 2022 | seekingalpha.comOpsens GAAP EPS of -$0.03, revenue of $10.1M beats by $3.01M (OTCMKTS:OPSSF) - Seeking AlphaJuly 14, 2022 | finance.yahoo.comOPSENS ANNOUNCES THIRD QUARTER FISCAL 2022 FINANCIAL RESULTS WITH RECORD QUARTERLY REVENUES - Yahoo FinanceJuly 11, 2022 | finance.yahoo.comOpSens Awarded Interventional Specialty Diagnostics Agreement with Premier for OptoWire IIIJuly 7, 2022 | finance.yahoo.comOPSENS TO HOST THIRD QUARTER FISCAL YEAR 2022 FINANCIAL RESULTS CONFERENCE CALL ON THURSDAY, JULY 14May 20, 2022 | yahoo.com10 Summer Grocery Deals at TargetApril 13, 2022 | finance.yahoo.comOPSENS ANNOUNCES SECOND QUARTER FISCAL 2022 FINANCIAL RESULTSSee More Headlines Receive OPSSF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Opsens and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings1/21/2014Today6/17/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Medical Instruments & Supplies Sub-IndustryN/A Current SymbolOTCMKTS:OPSSF CUSIPN/A CIKN/A Webopsens.com Phone(418) 781-0333FaxN/AEmployees293Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 20 High-Yield Dividend Stocks that Could Ruin Your RetirementAlmost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.Get This Free Report Key ExecutivesMr. Alan W. Milinazzo (Age 63)Executive Chairman of the Board Comp: $73.47kMr. Louis Laflamme C.A.CPA, CPA, CEO, President & DirectorMr. Brad DavisChief Commercial OfficerMr. John HanniganChief Financial OfficerMr. Pierre PoulinCorporate ControllerKey CompetitorsAddLife AB (publ)OTCMKTS:ADDLFAnsellOTCMKTS:ANSLYAnsellOTCMKTS:ANSLFAsahi InteccOTC:AHICFBATM Advanced CommunicationsOTCMKTS:BTAVFView All Competitors OPSSF Stock Analysis - Frequently Asked Questions Should I buy or sell Opsens stock right now? 1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Opsens in the last twelve months. There are currently 1 hold rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" OPSSF shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in OPSSF, but not buy additional shares or sell existing shares. View OPSSF analyst ratings or view top-rated stocks. How have OPSSF shares performed in 2024? Opsens' stock was trading at $2.1389 at the start of the year. Since then, OPSSF shares have increased by 0.0% and is now trading at $2.1389. View the best growth stocks for 2024 here. How were Opsens' earnings last quarter? Opsens Inc. (OTCMKTS:OPSSF) announced its quarterly earnings results on Tuesday, January, 21st. The company reported ($0.01) EPS for the quarter. How do I buy shares of Opsens? Shares of OPSSF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:OPSSF) was last updated on 6/18/2024 by MarketBeat.com Staff From Our PartnersBigger Than NVIDIA?With NVIDIA flying high, everyone is looking for the next breakout stock. But right now... There's only ...Behind the Markets | SponsoredBeta testers blew this thing upThis AI trading tool is probably unlike anything you've ever seen before… It scans the entire market and fi...Prosper Trading Academy | SponsoredRadical change coming — do this NOW to protect yourselfI recently uncovered a way the government could use the next crisis as a pretext to gain more control … and ra...Weiss Ratings | SponsoredAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredThe #1 Crypto That You Don’t Own… YetThere’s all kinds of “signals” to follow when investing in cryptos. But there’s one signal you should pay a...Crypto 101 Media | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | SponsoredInflation Is Robbing You Blind! Here’s How to Fight Back!Quietly, inflation has reduced your purchasing power by 29.4% since 2014. So something that cost $100 in 20...American Alternative | SponsoredUnexpected twist to Trump’s trialUnexpected Twist to Trump's Trial Most folks sense there's more to the Trump trial than meets the eye. B...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Opsens Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Opsens With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.